Charee Francisvogelsang
CIK 1223815 · View on SEC EDGAR ↗
First SEC filing: Feb. 13, 2004 · Latest: Feb. 13, 2004
On this page
Insider at
Insider transactions
Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted
No open-market trades on record; showing all filings.
| Date | Ticker | Code | Shares | Price | Value | Owned after | Δ own | A/D | vs now |
|---|---|---|---|---|---|---|---|---|---|
| Feb. 11, 2004 | DBD | A | 3,960 | $53.00 | $209,880 | 24,737 Direct | +19.06% | Acquired | 28.5% (price as of 2026-08-21) |
| Feb. 11, 2004 | DBD | F | 1,703 | $53.00 | $90,259 | 23,034 Direct | -6.88% | Disposed | 28.5% (price as of 2026-08-21) |
| Feb. 11, 2004 | DBD | A | 6,000 | $53.10 | $318,600 | 6,000 Direct | — | Acquired | 28.2% (price as of 2026-08-21) |
| Sept. 9, 2003 | DBD | F | 1,155 | $49.99 | $57,738 | 20,777 Direct | -5.27% | Disposed | 36.2% (price as of 2026-08-21) |
P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding
Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.
Derivative holdings (Form 4 Table II)
Options, RSUs and convertible securities reported on Form 4 Table II.
| Date | Ticker | Security | Underlying | Exercise price | Expiration | Shares | A/D |
|---|---|---|---|---|---|---|---|
| Feb. 11, 2004 | DBD | Non-Qualified Stock Option | Common Stock (6,000) | $53.10 | Feb. 10, 2014 | 6,000 | Acquired |
Exercise/conversion price is blank when not applicable (e.g. RSUs).